Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status
Tau Pathology
Tau protein
Tangle
Tauopathy
DOI:
10.1007/s00401-024-02760-8
Publication Date:
2024-07-09T09:02:50Z
AUTHORS (22)
ABSTRACT
Abstract This study investigates various pathological tau isoforms in the retina of individuals with early and advanced Alzheimer’s disease (AD), exploring their connection status. Retinal cross-sections from predefined superior-temporal inferior-temporal subregions corresponding brains neuropathologically confirmed AD patients a clinical diagnosis either mild cognitive impairment (MCI) or dementia ( n = 45) were compared retinas age- sex-matched normal cognition 30) non-AD 4). isoforms, including tangles, paired helical filament (PHF-tau), oligomeric-tau (Oligo-tau), hyperphosphorylated-tau (p-tau), citrullinated-tau (Cit-tau), stereologically analyzed by immunohistochemistry Nanostring GeoMx digital spatial profiling, correlated neuropathological outcomes. Our data indicated significant increases AD-related pretangle especially p-tau (AT8, 2.9-fold, pS396-tau, 2.6-fold), Cit-tau at arginine residue 209 (CitR -tau; 4.1-fold), Oligo-tau (T22 + , 9.2-fold), as well mature tangle forms like MC-1-positive (1.8-fold) PHF-tau (2.3-fold), to control retinas. MCI also exhibited substantial (5.2-fold), CitR -tau (3.5-fold), pS396-tau (2.2-fold). analysis elevated retinal epitopes: Ser214 Ser396 (2.6-fold), Ser404 (2.4-fold), Thr231 (1.8-fold), particularly patients. Strong associations found between versus brain pathology status: a) vs. Braak stage, neurofibrillary tangles (NFTs), CDR scores ρ 0.63–0.71), b) neuropil threads (NTs) ABC 0.69–0.71), c) NTs, NFTs, 0.67–0.74). Notably, strongly Aβ 42 arterial 40 r 0.76–0.86). Overall, this identifies quantifies diverse patients, underscoring link cognition. These findings advocate for further exploration tauopathy biomarkers facilitate detection monitoring via noninvasive imaging.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (90)
CITATIONS (11)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....